Skip to main content
Log in

Lipid-lowering effect of 2 dosages of a soy protein supplement in Hypercholesterolemia

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

The lipid-lowering effect of a soy-based protein supplement was evaluated in an 8-week randomized, placebo-controlled trial in patients with hypercholesterolemia. A total of 117 patients (63 men and 54 women) received soy protein, either 15 or 25 g/d or placebo. In the active treatment groups low-density lipoprotein cholesterol levels decreased significantly by 5.9% and 1.1 % respectively, but increased by 3.6% with placebo. Total serum cholesterol and apolipoprotein B levels changed significantly in a similar manner. High-density lipoprotein cholesterol, triglycerides, homocysteine, folic acid, and vitamin B12 levels did not change significantly compared with baseline in any of the study groups. All preparations were well tolerated. Soy protein 25 g/d was twice as effective as 15 g/d. In conclusion, soy protein supplementation may effectively reduce serum cholesterol levels and therefore is likely to diminish the risk for cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Riesen WF. Fettstoffwechsel. In: Thomas L, ed.Labor und Diagnose. Frankfurt/Main, Germany: TH-Books Verlagsgesellschaft mbH; 1998:171–190.

    Google Scholar 

  2. Brönstrup A, Pietrzik K. Bedeutung von Homocysteine bei der Entstehung von Atherosklerose: ist eine Supplementierung von Vitaminen sinnvoll?Ernährungs-Umschau. 1996;43:80–87.

    Google Scholar 

  3. Müller-Bohn T. Atheroskleroseprophylaxe-Bericht zum Fortbildungskongress In Malente.Deutsche Apotheker-Zeitung. 1996;136:2453–2458.

    Google Scholar 

  4. Shepherd J, Cobbe SM, Ford I, et al. Prävention der KHK durch Pravastatin bei Männern mit Hypercholesterinämie.Münch Med Wschr. 1996;138:21–28.

    Google Scholar 

  5. Glore SR, an Treeck D, Knehans AW, Guild M. Soluble fiber and serum lipids: a literature review.J Am Diet Assoc. 1994;94:425–436.

    Article  PubMed  CAS  Google Scholar 

  6. Peters P, Peters KM, Saborowski F, et al. Lipidsenkung mit Ballaststoffen.Akt Ernähr-Med. 1990;15:119–122.

    Google Scholar 

  7. Messena M, Erdman JW Jr, eds. First international symposium on the role of soy in preventing and treating chronic disease.J Nutr. 1995;125(suppl):567S–808S.

    Google Scholar 

  8. Sirtori CR, Lovati MR, Manzoni C, et al. Reductions of serum cholesterol by soy proteins: clinical experience and potential molecular mechanism.Nutr Metab Cardiovasc Dis. 1998;8:334–340.

    CAS  Google Scholar 

  9. Gianazza E, Eberini I, Arnoldi A, Wait R, Sirtori CR. A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies.J Nutr. 2003;133:9–14.

    PubMed  CAS  Google Scholar 

  10. Anderson JW. Diet first, then medication for hypercholesterolemia.JAMA. 2003;290:531–533.

    Article  PubMed  Google Scholar 

  11. Lovati MR. Alfa prime subunit of soybean beta conglycinin: in vitro and in vivo activity on cholesterol homeostasis. Presented at: 5th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; September, 2003; Orlando, Fla.

  12. Tsai AC, Mott EL, Owen GM, Bennick MR, Lo GS, Steinke FH. Effects of soy polysaccharide on gastrointestinal functions, nutrient balance, steroid excretions, glucose tolerance, serum lipids, and other parameters in humans.Am J Clin Nutr. 1983;38:504–511.

    PubMed  CAS  Google Scholar 

  13. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological and mechanistic evidence.J Clin Endocrinol Metab. 1998;83:2223–2235.

    Article  PubMed  CAS  Google Scholar 

  14. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids.N Engl J Med. 1995;333:276–282.

    Article  PubMed  CAS  Google Scholar 

  15. Baum JA, Teng H, Erdman JW, et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women.Am J Clin Nutr. 1998;68:545–551.

    PubMed  CAS  Google Scholar 

  16. Wong WW, Smith EOB, Stuff JE, Hachey DL, Heird WC, Pownell HJ. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men.Am J Clin Nutr. 1998;68(suppl):1385S-1389S.

    PubMed  CAS  Google Scholar 

  17. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins.Arch Intern Med. 1999;159:2070–2076.

    Article  PubMed  CAS  Google Scholar 

  18. Washburn S, Burke GL, Morgan T, Anthony M. Effects of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women.Menopause. 1999;6:7–13.

    Article  PubMed  CAS  Google Scholar 

  19. Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women.Am J Clin Nutr. 2000;71:1462–1469.

    PubMed  CAS  Google Scholar 

  20. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Hassler CM. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men.Am J Clin Nutr. 2000;71:1077–1084.

    PubMed  CAS  Google Scholar 

  21. Hermansen K, Sondergaard M, Høie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.Diabetes Care. 2001;24:228–233.

    Article  PubMed  CAS  Google Scholar 

  22. Puska P, Korpelainen V, Høie LM, Sksovlund E, Lahti E, Smerud KT. Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial.Eur J Clin Nutr. 2002;56:352–357.

    Article  PubMed  CAS  Google Scholar 

  23. Tonstad S, Smerud KT, Høie LM. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects.Am J Clin Nutr. 2002;76:78–84.

    PubMed  CAS  Google Scholar 

  24. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women.Am J Clin Nutr. 2000; 73:225–231.

    Google Scholar 

  25. Brunner E, Domhof S, Langer F.Nonparametric Analysis of Longitudinal Data in Factorial Experiments. New York, NY: Wiley & Sons; 2002.

    Google Scholar 

  26. Bathke A, Brunner E. A nonparametric alternative to analysis of covariance. In: Akritas MG, Politis DN, eds.Recent Advances and Trends in Nonparametric Statistics. Amsterdam, the Netherlands: Elsevier BV; 2003:109–120.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Høie, L.H., Graubaum, HJ., Harde, A. et al. Lipid-lowering effect of 2 dosages of a soy protein supplement in Hypercholesterolemia. Adv Therapy 22, 175–186 (2005). https://doi.org/10.1007/BF02849888

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1007/BF02849888

Keywords